Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 8, Issue 1, Pages 73-82Publisher
TAYLOR & FRANCIS AS
DOI: 10.1586/14737159.8.1.73
Keywords
cytokine signaling; diagnostics; hematology; Jak-Stat pathway; leukemia; myeloproliferation; oncology; Stat5; therapeutics
Categories
Ask authors/readers for more resources
The Jak-Stat-Socs pathway is an important component of cytokine receptor signaling. Not surprisingly, perturbation of this pathway is implicated in diseases of hernatopoietic and immune origin, including leukemia, lymphoma and immune deficiencies. This review examines the role of a key component of this pathway, Stat5. This has been shown to be activated in a variety of leukemias and myeloproliferative disorders, including downstream of a range of key oncogenes where it has been shown to play an important role in mediating their effects. Therefore, Stat5 represents a useful pan-leukemia/myeloproliferative disorder diagnostic marker and key therapeutic end point, as well as representing an attractive therapeutic target for these disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available